Bristol-Myers Squibb - Madison, NJ
posted about 2 months ago
The Senior Medical Director, US Lymphoma/CLL will report to the Executive Director, US Medical Multiple Myeloma/Lymphoma Disease Lead. This position is headquartered in Madison, NJ, and involves leading a team of physicians (MDs), pharmacists, and scientists to provide scientific and medical leadership for approved products in the Lymphoma Therapeutic Area, as well as compounds in various stages of clinical development, with a priority focus on Celmods and Nivolumab. The individual will engage in integrated strategic planning within US Medical, collaborating with partners in WW Medical, WW commercial, Clinical Research and Development, Regulatory, Translational Development, and Market Access. The Senior Medical Director will be responsible for the execution of the medical plan for the therapeutic area, ensuring alignment with the overall US and World Wide Medical strategy. This role will represent US Medical in lymphoma, impacting the US business and the overall Medical organization significantly. Key responsibilities include overseeing the medical affairs strategy and alignment, strategic and tactical planning, and ensuring appropriate cross-functional partnerships. The Senior Medical Director will manage the Lymphoma team, which includes MDs, pharmacists, and scientists, and will be accountable for executing medical affairs-led BMS-sponsored clinical trials while maintaining compliance, quality, and budget standards. The role also involves driving data generation efforts to support both Lymphoma inline and pipeline products, representing US Medical as a Lymphoma therapeutic area expert, and providing training and support to ensure superior operational and strategic skills within the team. The position requires interaction with key stakeholders, both internal and external, including investigators, KOLs, and advocacy groups. The Senior Medical Director will also collaborate with finance and the Disease lead to support planning of timelines, resources, and budgets, ensuring effective tracking and reporting against plans. This role is critical in shaping the medical strategy for the Lymphoma portfolio and ensuring successful product launches and ongoing support for existing products.